4//SEC Filing
Halpin Michael 4
Accession 0001140361-25-005253
CIK 0000887359other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:05 PM ET
Size
19.2 KB
Accession
0001140361-25-005253
Insider Transaction Report
Form 4
Vericel CorpVCEL
Halpin Michael
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18+5,250→ 11,858 total - Tax Payment
Common Stock
2025-02-18$57.28/sh−2,577$147,611→ 9,281 total - Exercise/Conversion
Common Stock
2025-02-18+3,825→ 13,106 total - Tax Payment
Common Stock
2025-02-18$57.28/sh−1,812$103,791→ 11,294 total - Exercise/Conversion
Common Stock
2025-02-19+2,813→ 14,107 total - Tax Payment
Common Stock
2025-02-19$57.78/sh−1,332$76,963→ 12,775 total - Exercise/Conversion
Restricted Stock Unit
2025-02-18+5,250→ 10,500 total→ Common Stock (5,250 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-18+3,825→ 3,825 total→ Common Stock (3,825 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-19+2,813→ 0 total→ Common Stock (2,813 underlying)
Footnotes (9)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2026, and February 17, 2027, respectively.
- [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
- [F4]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest on February 18, 2026.
- [F5]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021.
- [F6]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F7]No expiration date for this type of award.
- [F8]The Fair Market Value of the vested derivative securities is $57.28 per share.
- [F9]The Fair Market Value of the vested derivative securities is $57.78 per share.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001778858
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:05 PM ET
- Size
- 19.2 KB